SMN2 and proximal spinal muscular atrophy: The researcher designed an ASOs targeting SMN-AS1, which significantly enhance SMN2 transcription levels and SMN protein synthesis and demonstrate therapeutic efficacy in improving the motor function of SMA mouse models [14].